Elevation Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELEV and other ETFs, options, and stocks.

About ELEV

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion.

CEO

Joseph J. Ferra

CEOJoseph J. Ferra

Employees

Employees29

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2019

Founded2019

Employees

Employees29

ELEV Key Statistics

Market cap

180.01M

Market cap180.01M

Price-Earnings ratio

-3.59

Price-Earnings ratio-3.59

Dividend yield

—

Dividend yield—

Average volume

1.13M

Average volume1.13M

High today

$4.13

High today$4.13

Low today

$3.69

Low today$3.69

Open price

$3.86

Open price$3.86

Volume

431.64K

Volume431.64K

52 Week high

$5.89

52 Week high$5.89

52 Week low

$0.363

52 Week low$0.363

Elevation Oncology

Why Robinhood?

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. Show more

ELEV Key Statistics

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion.